Clinical Outcomes of Repeated Radioactive Iodine Therapy for Graves’ Disease
Sign Up to like & getrecommendations! Published in 2022 at "Endocrinology and Metabolism"
DOI: 10.3803/enm.2022.1418
Abstract: Background Radioactive iodine (RAI) therapy is a successful therapeutic modality for Graves’ disease. However, RAI therapy can fail, and RAI therapy after antithyroid drugs (ATDs) has a lower remission rate. Therefore, many patients require repeated… read more here.
Keywords: 2nd rai; radioactive iodine; rai therapy; therapy ... See more keywords